TNSN07226A1 - Taurine synthesis, production and utility as a medicine - Google Patents

Taurine synthesis, production and utility as a medicine

Info

Publication number
TNSN07226A1
TNSN07226A1 TNP2007000226A TNSN07226A TNSN07226A1 TN SN07226 A1 TNSN07226 A1 TN SN07226A1 TN P2007000226 A TNP2007000226 A TN P2007000226A TN SN07226 A TNSN07226 A TN SN07226A TN SN07226 A1 TNSN07226 A1 TN SN07226A1
Authority
TN
Tunisia
Prior art keywords
taurine
medicine
production
utility
bile salts
Prior art date
Application number
TNP2007000226A
Other languages
English (en)
Inventor
Magd Ahmed Kotb Abdalla
Original Assignee
Magd Ahmed Kotb Abdalla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magd Ahmed Kotb Abdalla filed Critical Magd Ahmed Kotb Abdalla
Publication of TNSN07226A1 publication Critical patent/TNSN07226A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TNP2007000226A 2005-01-05 2007-06-14 Taurine synthesis, production and utility as a medicine TNSN07226A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EG2005010013 2005-01-05
PCT/EG2005/000044 WO2006072259A2 (fr) 2005-01-05 2005-12-31 Synthese de taurine, production et utilisation de celle-ci comme medicament

Publications (1)

Publication Number Publication Date
TNSN07226A1 true TNSN07226A1 (en) 2008-11-21

Family

ID=36647837

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2007000226A TNSN07226A1 (en) 2005-01-05 2007-06-14 Taurine synthesis, production and utility as a medicine

Country Status (15)

Country Link
EP (1) EP1844006A2 (fr)
JP (1) JP2008526789A (fr)
KR (1) KR20070091198A (fr)
CN (1) CN101146767A (fr)
AP (1) AP2007004084A0 (fr)
AU (1) AU2005324199A1 (fr)
BR (1) BRPI0519606A2 (fr)
CA (1) CA2593563A1 (fr)
EA (1) EA200701434A1 (fr)
IL (1) IL184221A0 (fr)
MA (1) MA29238B1 (fr)
MX (1) MX2007008196A (fr)
NO (1) NO20074937A (fr)
TN (1) TNSN07226A1 (fr)
WO (1) WO2006072259A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101932238B (zh) 2007-11-30 2015-04-08 加利福尼亚大学董事会 使用半胱胺制品治疗非酒精性脂肪性肝炎(nash)的方法
CN103382170B (zh) * 2012-10-25 2015-04-08 潜江永安药业股份有限公司 一种牛磺酸的制备方法
CN106728405A (zh) * 2016-11-15 2017-05-31 陈思文 一种牛磺酸和水溶性茶多酚复方组合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58140017A (ja) * 1981-12-22 1983-08-19 Junichi Azuma 心不全治療剤
JPH08208464A (ja) * 1994-12-02 1996-08-13 Taisho Pharmaceut Co Ltd 高脂血症の治療及び予防薬
US6184227B1 (en) * 1995-07-21 2001-02-06 Savvipharm Inc. Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
SE9601395D0 (sv) * 1996-04-12 1996-04-12 Dieter Haeussinger New therapeutic treatment 1
GB9722361D0 (en) * 1997-10-24 1997-12-17 Pharma Nord Uk Ltd Pharmaceutical formulation for treating liver disorders
NZ527924A (en) * 1999-01-29 2005-01-28 Mars Uk Ltd Antioxidant compositions and methods for companion animals
AU8003800A (en) * 1999-10-08 2001-04-23 Joyce Corinne Bechthold Methods and compositions for treating neurobehavioral disorders
CN1340502A (zh) * 2000-06-30 2002-03-20 张永春 牛磺酸合锌的生产工艺
CN1268733C (zh) * 2004-07-20 2006-08-09 刘辉 牛磺酸功能啤酒及其生产工艺

Also Published As

Publication number Publication date
AU2005324199A1 (en) 2006-07-13
WO2006072259A2 (fr) 2006-07-13
MA29238B1 (fr) 2008-02-01
CN101146767A (zh) 2008-03-19
WO2006072259A3 (fr) 2007-10-04
JP2008526789A (ja) 2008-07-24
MX2007008196A (es) 2008-02-22
AP2007004084A0 (en) 2007-08-31
IL184221A0 (en) 2008-12-29
NO20074937A (no) 2007-09-28
EA200701434A1 (ru) 2008-10-30
EP1844006A2 (fr) 2007-10-17
KR20070091198A (ko) 2007-09-07
BRPI0519606A2 (pt) 2009-02-25
CA2593563A1 (fr) 2006-07-13

Similar Documents

Publication Publication Date Title
UA93043C2 (ru) ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ ДЛЯ ПОЛУЧЕНИЯ ТРАНС-5-ХЛОР-2-МЕТИЛ-2,3,3А,12В-ТЕТРАГИДРО-1Н-ДИБЕНЗ[2,3:6,7]ОКСЕПИНО[4,5-с]ПИРОЛА
MX2007008980A (es) Acidos nucleicos para apoptosis de celulas cancerigenas.
WO2006020722A3 (fr) Compositions pharmaceutiques de beta-lapachone et d&#39;analogues de beta-lapachone possedant un potentiel de ciblage de tumeur ameliore
NO20064676L (no) Farmasoytiske salter av 3-0-(3&#39;3&#39;-dimetylsuccinyl)betulinsyre
WO2009062118A3 (fr) Régulation du trafic de protéines
MX2010005966A (es) Conjugados de anticuerpo monoclonal-molecula asociada dirigidos a la proteina tirosina-cinasa 7 (ptk7).
WO2007062610A3 (fr) Structure polymere semblable a un dendrimere pour l&#39;obtention de conjugues a interet pharmaceutique
WO2008006038A3 (fr) Procédés et compositions pour produire du butanol
BR0015148A (pt) Produção androgenética ou ginogenética de linhas de células e células pluripotentes, e seu uso para produzir tecidos e células diferenciados
Metzner et al. Serotonin, l‐tryptophan, and tryptamine are effective inhibitors of the amino acid transport system PAT1
DE60024242D1 (de) Verwendung von lipoxinen zur inhibierung von tnf-alpha initiierter gegenreaktion
GEP20115206B (en) Novel piperidine carboxylic acid amide derivatives
TNSN07226A1 (en) Taurine synthesis, production and utility as a medicine
EA200702094A1 (ru) Производные гетероарилмочевины, пригодные для ингибирования chk1
WO2008049920A3 (fr) Variantes il-21
WO2007019541A3 (fr) Compositions d&#39;anticorps, methodes de traitement de maladie neoplasique et methodes de regulation de la fertilite
WO2007006095A3 (fr) Immunomodulation induite par la chaperonine 10
HK1129071A1 (en) Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
WO2007017510A3 (fr) Diamides d&#39;acide isophtalique pour le traitement de la maladie d&#39;alzheimer
EP1645288A1 (fr) Nouveaux régulateurs des facteurs de transcription nucleaire
WO2007036771A3 (fr) Nouvelle forme cristalline solide d&#39;acide libre de pantoprazole, sels dérivés de celle-ci, et procédés permettant leur préparation
WO2006105199A3 (fr) Compositions et methodes de synthese d&#39;un peptide et d&#39;un conjugue apparente
ID27240A (id) Proses untuk pembuatan fermentatif asam d-pantotenik dengan menggunakan bakteri coryneform
MX2007008281A (es) Preparacion de sales farmaceuticas de compuestos de piperazina.
WO2006007565A3 (fr) Nouveau variants cd40